Researchers reviewed data from 10 randomized trials to track the outcomes of 22,638 patients who underwent a percutaneous coronary intervention.
While most patients (91 percent) were white, only 19 percent had an adverse cardiac event within five years, compared to 24 percent of Black patients.
People of color who participated in the trials had more chronic health issues than white participants, researchers said.
“After accounting for these differences, Black race was an independent predictor of worse outcomes, whereas Hispanic ethnicity and Asian race were not,” they said.
To view the full study, click here.
More articles on cardiology:
FDA clears Apple Watch ECG for remote patient visits during pandemic: 6 things to know
Cincinnati Children’s to develop mobile rheumatic heart disease tech
Over one-third of hospitalized COVID-19 patients had heart damage, study shows
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.